1hhu

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /><applet load="1hhu" size="450" color="white" frame="true" align="right" spinBox="true" caption="1hhu, resolution 0.89&Aring;" /> '''BALHIMYCIN IN COMPLE...)
Line 1: Line 1:
-
[[Image:1hhu.jpg|left|200px]]<br /><applet load="1hhu" size="450" color="white" frame="true" align="right" spinBox="true"
+
[[Image:1hhu.jpg|left|200px]]<br /><applet load="1hhu" size="350" color="white" frame="true" align="right" spinBox="true"
caption="1hhu, resolution 0.89&Aring;" />
caption="1hhu, resolution 0.89&Aring;" />
'''BALHIMYCIN IN COMPLEX WITH D-ALA-D-ALA'''<br />
'''BALHIMYCIN IN COMPLEX WITH D-ALA-D-ALA'''<br />
==Overview==
==Overview==
-
The vancomycin-related antibiotics balhimycin and degluco-balhimycin have, been crystallized in complexes with di-, tri- and pentapeptides that, emulate bacterial cell-wall precursors, and four structures determined at, atomic resolution (&lt;1 A). In addition to the features expected from, previous structural and spectroscopic studies, two new motifs were, observed that may prove important in the design of antibiotics modified to, overcome bacterial resistance. A changed binding mode was found in two, dipeptide complexes, and a new type of face-to-face oligomerization (in, addition to the well-established back-to-back dimerization) was seen when, the model peptide reaches a critical fraction of the size of the cell-wall, precursor pentapeptide. The extensive interactions involving both, antibiotic and peptide molecules in this interface should appreciably, enhance the kinetic and thermodynamic stability of the complexes. In the, pentapeptide complex, the relative positions of the peptides are close to, those required for d-Ala elimination, so this structure may provide a, realistic model for the prevention of the enzyme-catalyzed cell-wall, crosslinking by antibiotic binding.
+
The vancomycin-related antibiotics balhimycin and degluco-balhimycin have been crystallized in complexes with di-, tri- and pentapeptides that emulate bacterial cell-wall precursors, and four structures determined at atomic resolution (&lt;1 A). In addition to the features expected from previous structural and spectroscopic studies, two new motifs were observed that may prove important in the design of antibiotics modified to overcome bacterial resistance. A changed binding mode was found in two dipeptide complexes, and a new type of face-to-face oligomerization (in addition to the well-established back-to-back dimerization) was seen when the model peptide reaches a critical fraction of the size of the cell-wall precursor pentapeptide. The extensive interactions involving both antibiotic and peptide molecules in this interface should appreciably enhance the kinetic and thermodynamic stability of the complexes. In the pentapeptide complex, the relative positions of the peptides are close to those required for d-Ala elimination, so this structure may provide a realistic model for the prevention of the enzyme-catalyzed cell-wall crosslinking by antibiotic binding.
==About this Structure==
==About this Structure==
-
1HHU is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Amycolatopsis_sp. Amycolatopsis sp.] with BMY, CIT and MPD as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1HHU OCA].
+
1HHU is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Amycolatopsis_sp. Amycolatopsis sp.] with <scene name='pdbligand=BMY:'>BMY</scene>, <scene name='pdbligand=CIT:'>CIT</scene> and <scene name='pdbligand=MPD:'>MPD</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1HHU OCA].
==Reference==
==Reference==
Line 15: Line 15:
[[Category: Bunkoczi, G.]]
[[Category: Bunkoczi, G.]]
[[Category: Lehmann, C.]]
[[Category: Lehmann, C.]]
-
[[Category: Sheldrick, G.M.]]
+
[[Category: Sheldrick, G M.]]
[[Category: Vertessy, L.]]
[[Category: Vertessy, L.]]
[[Category: BMY]]
[[Category: BMY]]
Line 25: Line 25:
[[Category: vacomycin]]
[[Category: vacomycin]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Sun Nov 25 02:36:50 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 13:01:27 2008''

Revision as of 11:01, 21 February 2008


1hhu, resolution 0.89Å

Drag the structure with the mouse to rotate

BALHIMYCIN IN COMPLEX WITH D-ALA-D-ALA

Overview

The vancomycin-related antibiotics balhimycin and degluco-balhimycin have been crystallized in complexes with di-, tri- and pentapeptides that emulate bacterial cell-wall precursors, and four structures determined at atomic resolution (<1 A). In addition to the features expected from previous structural and spectroscopic studies, two new motifs were observed that may prove important in the design of antibiotics modified to overcome bacterial resistance. A changed binding mode was found in two dipeptide complexes, and a new type of face-to-face oligomerization (in addition to the well-established back-to-back dimerization) was seen when the model peptide reaches a critical fraction of the size of the cell-wall precursor pentapeptide. The extensive interactions involving both antibiotic and peptide molecules in this interface should appreciably enhance the kinetic and thermodynamic stability of the complexes. In the pentapeptide complex, the relative positions of the peptides are close to those required for d-Ala elimination, so this structure may provide a realistic model for the prevention of the enzyme-catalyzed cell-wall crosslinking by antibiotic binding.

About this Structure

1HHU is a Protein complex structure of sequences from Amycolatopsis sp. with , and as ligands. Full crystallographic information is available from OCA.

Reference

Structures of glycopeptide antibiotics with peptides that model bacterial cell-wall precursors., Lehmann C, Bunkoczi G, Vertesy L, Sheldrick GM, J Mol Biol. 2002 May 3;318(3):723-32. PMID:12054818

Page seeded by OCA on Thu Feb 21 13:01:27 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools